KYMR
Kymera Therapeutics, Inc. Common Stock
$114.11
-0.01%
-0.01
Notify me if price changes either direction
Buy KYMR stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
9.4B
Enterprise value
8.5B
Trailing PE
-30.924119241192
Forward PE
-26.060116
PEG Ratio
2.3052525252525
Enterprise to EBITDA
-24.415
Enterprise to revenue
165.335
Price to book MRQ
6.0478277
Price to sales TTM
181.05106
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
51.5M
EBITDA
-348584992
Diluted EPS TTM
-3.58
Total Cash (MRQ)
650.9M
Current ratio (MRQ)
10.814
Operating Cash Flow (TTM)
-242580992
KYMR trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
July 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
